Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.264SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.581SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.330SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.205SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.177SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.301SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.308SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.210SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.325SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.590SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.116SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.496SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.438.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AY.49 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.357SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.177.46SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
A.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.530SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.2.75.8SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
CH.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.570SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.633SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.136SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XAYSYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XAESYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.467SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.484SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.476SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
A.18SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.404SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
CV.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BR.5.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.2.75.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XAASYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.501SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.226SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.546SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.194SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.429.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
P.1.9 (Gamma)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AY.25.1.1 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.203SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.157SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.176SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AY.3.4 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.391SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.393SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.432SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.388SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
P.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used